litlas
Log inCreate account

David R. Byrd

Active 1995–2022

48
Papers
23,981
Citations
46
h-index
48
i10-index

Citations

Citations per year for David R. Byrd1996: 3 citations1997: 4 citations1998: 8 citations1999: 15 citations2000: 23 citations2001: 50 citations2002: 80 citations2003: 77 citations2004: 68 citations2005: 68 citations2006: 75 citations2007: 66 citations2008: 66 citations2009: 76 citations2010: 80 citations2011: 148 citations2012: 170 citations2013: 161 citations2014: 152 citations2015: 132 citations2016: 113 citations2017: 139 citations2018: 155 citations2019: 623 citations2020: 866 citations2021: 752 citations2022: 516 citations2023: 420 citations2024: 785 citations2025: 265 citations2026: 13 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,480 citing papers, 25.1% of this breakdownChina: 1,061 citing papers, 10.7% of this breakdownItaly: 687 citing papers, 6.9% of this breakdownGermany: 539 citing papers, 5.5% of this breakdownUnited Kingdom: 519 citing papers, 5.2% of this breakdownAustralia: 436 citing papers, 4.4% of this breakdownFrance: 389 citing papers, 3.9% of this breakdownNetherlands: 386 citing papers, 3.9% of this breakdownCanada: 299 citing papers, 3% of this breakdownSpain: 253 citing papers, 2.6% of this breakdownJapan: 231 citing papers, 2.3% of this breakdownSwitzerland: 186 citing papers, 1.9% of this breakdown
0%25.1%Other 24.6%

Institutions

Fields

  • Medicine74.2%
  • Biochemistry, Genetics and Molecular Biology17.1%
  • Immunology and Microbiology4.4%
  • Computer Science1.3%
  • Engineering1.1%
  • Health Professions0.2%
  • Other1.7%

Topics

  • Cutaneous Melanoma Detection and Management7.5%
  • Melanoma and MAPK Pathways4.1%
  • Cancer Immunotherapy and Biomarkers3.9%
  • Immunotherapy and Immune Responses3.6%
  • Nonmelanoma Skin Cancer Studies3.1%
  • CAR-T cell therapy research2.1%
  • Other75.7%

Coauthors

All papers

Open in search
  1. The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population‐based to a more “personalized” approach to cancer staging

    Authors: Mahul B. Amin, Frederick L. Greene, Stephen B. Edge, Carolyn C. Compton, Jeffrey E. Gershenwald, Robert K. Brookland, Laura Meyer, Donna M. Gress, David R. Byrd, David P. Winchester - CA A Cancer Journal for Clinicians 2017 cited by 6,520

  2. Final Version of 2009 AJCC Melanoma Staging and Classification

    Authors: Charles M. Balch, Jeffrey E. Gershenwald, Seng-Jaw Soong, John F. Thompson, Michael B. Atkins, David R. Byrd, Antônio C. Buzaid, Alistair J. Cochran, Daniel G. Coit, Shouluan Ding, Alexander M.M. Eggermont, Keith T. Flaherty, Phyllis A. Gimotty, John M. Kirkwood, Kelly M. McMasters, Martín C. Mihm, Donald L. Morton, Merrick I. Ross, Arthur J. Sober, Vernon K. Sondak - Journal of Clinical Oncology 2009 cited by 4,570

  3. Neoantigen-specific CD4+ T cells in human melanoma have diverse differentiation states and correlate with CD8+ T cell, macrophage, and B cell function

    Authors: Joshua Veatch, Sylvia M. Lee, Carolyn Shasha, Naina Singhi, Julia Szeto, Ata S. Moshiri, Teresa S. Kim, Kimberly S. Smythe, Paul Kong, Matthew Fitzgibbon, Brenda L. Jesernig, Shailender Bhatia, Scott S. Tykodi, Evan Hall, David R. Byrd, John A. Thompson, Venu G. Pillarisetty, Thomas Duhen, A. McGarry Houghton, Evan W. Newell, Raphaël Gottardo, Stanley R. Riddell - Cancer Cell 2022 cited by 144

  4. Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma

    Authors: Mark B. Faries, John F. Thompson, Alistair J. Cochran, Robert H.I. Andtbacka, Nicola Mozzillo, Jonathan S. Zager, Tiina Jahkola, Tawnya L. Bowles, Alessandro Testori, Peter D. Beitsch, Harald J. Hoekstra, Marc Moncrieff, Christian Ingvar, Michel W.J.M. Wouters, Michael S. Sabel, Edward A. Levine, Doreen M. Agnese, Michael A. Henderson, Reinhard Dummer, Carlo Riccardo Rossi, Rogerio I. Neves, Steven D. Trocha, Frances C. Wright, David R. Byrd, Maurice Matter, Eddy C. Hsueh, Alastair D. MacKenzie Ross, Douglas B. Johnson, Patrick Terheyden, Adam C. Berger, Tara L. Huston, Jeffrey D. Wayne, B. Mark Smithers, Heather B. Neuman, Schlomo Schneebaum, Jeffrey E. Gershenwald, Charlotte E. Ariyan, Darius C. Desai, Lisa K. Jacobs, Kelly M. McMasters, Anja Gesierich, Peter Hersey, Steven D. Bines, John M. Kane, Richard J. Barth, Gregory McKinnon, Jeffrey M. Farma, Erwin Schultz, Sergi Vidal‐Sicart, Richard Hoefer, James M. Lewis, Randall P. Scheri, Mark C. Kelley, Omgo E. Nieweg, R. Dirk Noyes, Dave S.�B. Hoon, He-Jing Wang, David Elashoff, Robert M. Elashoff - New England Journal of Medicine 2017 cited by 1,385

  5. The TNM classification of malignant tumours—towards common understanding and reasonable expectations

    Authors: Brian O’Sullivan, James D. Brierley, David R. Byrd, Fred T. Bosman, Sean Kehoe, Carol Kossary, Marion Piñeros, E. Van Eycken, Hannah K. Weir, Mary Gospodarowicz - The Lancet Oncology 2017 cited by 286

  6. Age-Specific Incidence of Melanoma in the United States

    Authors: Kelly G. Paulson, Deepti Gupta, Teresa S. Kim, Joshua Veatch, David R. Byrd, Shailender Bhatia, Katherine Y. Wojcik, Aude G. Chapuis, John A. Thompson, Margaret M. Madeleine, Jennifer M. Gardner - JAMA Dermatology 2019 cited by 224

  7. Prognostic Factors Analysis of 17,600 Melanoma Patients: Validation of the American Joint Committee on Cancer Melanoma Staging System

    Authors: Charles M. Balch, Seng‐Jaw Soong, Jeffrey E. Gershenwald, John F. Thompson, Douglas S. Reintgen, Natale Cascinelli, Marshall M. Urist, Kelly M. McMasters, Merrick I. Ross, John M. Kirkwood, Michael B. Atkins, John A. Thompson, Daniel G. Coit, David R. Byrd, Renée A. Desmond, Yuting Zhang, Ping‐Yu Liu, Gary H. Lyman, Aberto Morabito - Journal of Clinical Oncology 2001 cited by 2,401

  8. NCCN Guidelines Insights: Thyroid Carcinoma, Version 2.2018

    Authors: Robert I. Haddad, Christian Nasr, Lindsay Bischoff, Naifa L. Busaidy, David R. Byrd, Glenda G. Callender, Paxton V. Dickson, Quan‐Yang Duh, Hormoz Ehya, Whitney Goldner, Megan R. Haymart, Carl K. Hoh, Jason P. Hunt, Andrei Iagaru, Fouad Kandeel, Peter Kopp, Dominick Lamonica, Bryan McIver, Christopher D. Raeburn, John A. Ridge, Matthew D. Ringel, Randall P. Scheri, Jatin P. Shah, Rebecca S. Sippel, Robert C. Smallridge, Cord Sturgeon, Thomas N. Wang, Lori J. Wirth, Richard J. Wong, Alyse Johnson-Chilla, K Hoffmann, Lisa A. Gurski - Journal of the National Comprehensive Cancer Network 2018 cited by 370

  9. Intratumoral Delivery of Plasmid IL12 Via Electroporation Leads to Regression of Injected and Noninjected Tumors in Merkel Cell Carcinoma

    Authors: Shailender Bhatia, Natalie V. Longino, Natalie Miller, Rima M. Kulikauskas, Jayasri G. Iyer, Dafina Ibrani, Astrid Blom, David R. Byrd, Upendra Parvathaneni, Chris Twitty, Jean S. Campbell, Mai H. Le, Sharron Gargosky, Robert H. Pierce, Richard Heller, Adil Daud, Paul Nghiem - Clinical Cancer Research 2019 cited by 92

  10. Intratumoral G100, a TLR4 Agonist, Induces Antitumor Immune Responses and Tumor Regression in Patients with Merkel Cell Carcinoma

    Authors: Shailender Bhatia, Natalie J. Miller, Hailing Lu, Natalie V. Longino, Dafina Ibrani, Michi M. Shinohara, David R. Byrd, Upendra Parvathaneni, Rima M. Kulikauskas, Jan ter Meulen, Frank J. Hsu, David M. Koelle, Paul Nghiem - Clinical Cancer Research 2018 cited by 132

  11. Defining best practices for tissue procurement in immuno-oncology clinical trials: consensus statement from the Society for Immunotherapy of Cancer Surgery Committee

    Authors: Brian Gastman, Piyush K. Agarwal, Adam Berger, Genevieve M. Boland, Stephen Broderick, Lisa H. Butterfield, David R. Byrd, Peter E. Fecci, Robert L. Ferris, Yuman Fong, Stephanie L. Goff, Matthew M. Grabowski, Fumito Ito, Michael Lim, Michael T. Lotze, Haider Mahdi, Mokenge Malafa, Carol D. Morris, Pranav Murthy, Rogerio I. Neves, Adekunle Odunsi, Sara I. Pai, Sangeetha Prabhakaran, Steven A. Rosenberg, Ragheed Saoud, Jyothi Sethuraman, Joseph J. Skitzki, Craig L. Slingluff, Vernon K. Sondak, John B. Sunwoo, Simon Turcotte, Cecilia C.S. Yeung, Howard L. Kaufman - Journal for ImmunoTherapy of Cancer 2020 cited by 33

  12. Thyroid Carcinoma

    Authors: R. Michael Tuttle, Douglas W. Ball, David R. Byrd, Raza A. Dilawari, Gerard M. Doherty, Quan‐Yang Duh, Hormoz Ehya, William B. Farrar, Robert I. Haddad, Fouad Kandeel, Richard T. Kloos, Peter Kopp, Dominick Lamonica, Thom R. Loree, William M. Lydiatt, Judith C. McCaffrey, John A. Olson, Lee Parks, John A. Ridge, Jatin P. Shah, Steven I. Sherman, Cord Sturgeon, Steven G. Waguespack, Thomas N. Wang, Lori J. Wirth - Journal of the National Comprehensive Cancer Network 2010 cited by 205

  13. Prognostic Significance of Mitotic Rate in Localized Primary Cutaneous Melanoma: An Analysis of Patients in the Multi-Institutional American Joint Committee on Cancer Melanoma Staging Database

    Authors: John F. Thompson, Seng-Jaw Soong, Charles M. Balch, Jeffrey E. Gershenwald, Shouluan Ding, Daniel G. Coit, Keith T. Flaherty, Phyllis A. Gimotty, T. M. Johnson, Marcella M. Johnson, Stanley P. L. Leong, Merrick I. Ross, David R. Byrd, Natale Cascinelli, Alistair J. Cochran, Alexander M.M. Eggermont, Kelly M. McMasters, Martín C. Mihm, Donald L. Morton, Vernon K. Sondak - Journal of Clinical Oncology 2011 cited by 359

  14. Transcriptome-Wide Studies of Merkel Cell Carcinoma and Validation of Intratumoral CD8+ Lymphocyte Invasion As an Independent Predictor of Survival

    Authors: Kelly G. Paulson, Jayasri G. Iyer, Andrew Tegeder, Renee Thibodeau, Janell M. Schelter, S Koba, David Schrama, William Simonson, Bianca D. Lemos, David R. Byrd, David M. Koelle, Denise A. Galloway, J. Helen Leonard, Margaret M. Madeleine, Zsolt B. Argényi, Mary L. Disis, Juergen C. Becker, Michele A. Cleary, Paul Nghiem - Journal of Clinical Oncology 2011 cited by 296

  15. Merkel Cell Polyomavirus-Specific CD8+ and CD4+ T-cell Responses Identified in Merkel Cell Carcinomas and Blood

    Authors: Jayasri G. Iyer, Olga K. Afanasiev, Christopher L. McClurkan, Kelly G. Paulson, Kotaro Nagase, Lichen Jing, Joshua O. Marshak, Lichun Dong, J. W. S. Carter, Ivy Lai, Erik Farrar, David R. Byrd, Denise A. Galloway, Cassian Yee, David M. Koelle, Paul Nghiem - Clinical Cancer Research 2011 cited by 147

  16. Tumor Biology and Response to Chemotherapy Impact Breast Cancer-specific Survival in Node-positive Breast Cancer Patients Treated With Neoadjuvant Chemotherapy

    Authors: Judy C. Boughey, Karla V. Ballman, Linda McCall, Elizabeth A. Mittendorf, W. Fraser Symmans, Thomas B. Julian, David R. Byrd, Kelly K. Hunt - Annals of Surgery 2017 cited by 83

  17. Therapeutic Value of Sentinel Lymph Node Biopsy in Patients With Melanoma

    Authors: Jessica S. Crystal, John F. Thompson, John Hyngstrom, Corrado Caracò, Jonathan S. Zager, Tiina Jahkola, Tawnya L. Bowles, Elisabetta Pennacchioli, Peter D. Beitsch, Harald J. Hoekstra, Marc Moncrieff, Christian Ingvar, Alexander C. J. van Akkooi, Michael S. Sabel, Edward A. Levine, Doreen M. Agnese, Michael A. Henderson, Reinhard Dummer, Rogerio I. Neves, Carlo Riccardo Rossi, John M. Kane, Steven D. Trocha, Frances C. Wright, David R. Byrd, Maurice Matter, Eddy C. Hsueh, Alastair D. MacKenzie Ross, Mark C. Kelley, Patrick Terheyden, Tara L. Huston, Jeffrey D. Wayne, Heather B. Neuman, B. Mark Smithers, Charlotte E. Ariyan, Darius C. Desai, Jeffrey E. Gershenwald, Shlomo Schneebaum, Anja Gesierich, Lisa K. Jacobs, James M. Lewis, Kelly M. McMasters, Christina O’Donoghue, André van der Westhuizen, Armando Sardi, Richard J. Barth, Robert M. Barone, Jonathan McKinnon, Craig L. Slingluff, Jeffrey M. Farma, Erwin Schultz, Randall P. Scheri, Sergi Vidal‐Sicart, Manuel Alberto Molina, Alessandro Testori, Leland J. Foshag, Lisa Van Kreuningen, He-Jing Wang, Myung‐Shin Sim, Richard A. Scolyer, David Elashoff, Alistair J. Cochran, Mark B. Faries - JAMA Surgery 2022 cited by 44

  18. Adjuvant Radiation Therapy and Chemotherapy in Merkel Cell Carcinoma: Survival Analyses of 6908 Cases From the National Cancer Data Base

    Authors: Shailender Bhatia, Barry E. Storer, Jayasri G. Iyer, Ata S. Moshiri, Upendra Parvathaneni, David R. Byrd, Arthur J. Sober, Vernon K. Sondak, Jeffrey E. Gershenwald, Paul Nghiem - JNCI Journal of the National Cancer Institute 2016 cited by 228

  19. Pulsed radiofrequency for chronic pain

    Authors: David R. Byrd, Sean Mackey - Current Pain and Headache Reports 2008 cited by 226

  20. Age as a Predictor of Sentinel Node Metastasis among Patients with Localized Melanoma: An Inverse Correlation of Melanoma Mortality and Incidence of Sentinel Node Metastasis Among Young and Old Patients

    Authors: Charles M. Balch, John F. Thompson, Jeffrey E. Gershenwald, Seng-Jaw Soong, Shouluan Ding, Kelly M. McMasters, Daniel G. Coit, Alexander M.M. Eggermont, Phyllis A. Gimotty, Timothy M. Johnson, John M. Kirkwood, Stanley P. L. Leong, Merrick I. Ross, David R. Byrd, Alistair J. Cochran, Martín C. Mihm, Donald L. Morton, Michael B. Atkins, Keith T. Flaherty, Vernon K. Sondak - Annals of Surgical Oncology 2014 cited by 156

  21. Lymphedema symptoms and limb measurement changes in breast cancer survivors treated with neoadjuvant chemotherapy and axillary dissection: results of American College of Surgeons Oncology Group (ACOSOG) Z1071 (Alliance) substudy

    Authors: Jane M. Armer, Karla V. Ballman, Linda McCall, Nathan C. Armer, Yuanlu Sun, Tipparat Udmuangpia, Kelly K. Hunt, Elizabeth A. Mittendorf, David R. Byrd, Thomas B. Julian, Judy C. Boughey - Supportive Care in Cancer 2018 cited by 87

  22. Global Consultation on Cancer Staging: promoting consistent understanding and use

    Authors: James D. Brierley, Brian O’Sullivan, Hisao Asamura, David R. Byrd, Shao Hui Huang, Anne Lee, Marion Piñeros, Malcolm D. Mason, Fábio Ynoe de Moraes, Wiebke Rösler, Brian Rous, Julie Torode, J. Han van Krieken, Mary Gospodarowicz - Nature Reviews Clinical Oncology 2019 cited by 85

  23. Current and future cancer staging after neoadjuvant treatment for solid tumors

    Authors: David R. Byrd, James D. Brierley, Thomas P. Baker, Daniel C. Sullivan, Donna M. Gress - CA A Cancer Journal for Clinicians 2020 cited by 75

  24. Pathologic nodal evaluation improves prognostic accuracy in Merkel cell carcinoma: Analysis of 5823 cases as the basis of the first consensus staging system

    Authors: Bianca D. Lemos, Barry E. Storer, Jayasri G. Iyer, Jerri Linn Phillips, Christopher K. Bichakjian, Lekun Fang, Timothy M. Johnson, Nanette J. Liegeois-Kwon, Clark C. Otley, Kelly G. Paulson, Merrick I. Ross, Siegrid S. Yu, Nathalie C. Zeitouni, David R. Byrd, Vernon K. Sondak, Jeffrey E. Gershenwald, Arthur J. Sober, Paul Nghiem - Journal of the American Academy of Dermatology 2010 cited by 555